Criteria
The most widely used diagnostic criteria are those from the Diagnostic and statistical manual of mental disorders, 5th edition, text revision (DSM-5-TR).[2] The Schooler-Kane criteria are largely used for research purposes.[38] The Abnormal Involuntary Movement Scale and Impact-TD scale may be used to monitor severity of symptoms over time and impact on a patient's quality of life, respectively.[39] AIMS: toolbox of forms Opens in new window
Diagnostic and statistical manual of mental disorders, 5th edition, text revision (DSM-5-TR)[2]
DSM-5-TR describes the essential features of tardive dyskinesia (TD) as abnormal, involuntary movements of the tongue, jaw, trunk, or extremities that occur in association with the patient using dopamine receptor-blocking drugs. The involuntary movements must be present over a period of at least 4 weeks. The movements may vary in nature, but are distinct from the tremors seen in drug-induced parkinsonism.
The signs or symptoms develop during the patient's exposure to the dopamine receptor-blocking drug, within 4 weeks of withdrawal from an oral dopamine receptor-blocking drug, or within 8 weeks of withdrawal from a long-acting, injectable dopamine receptor-blocking drug.
The patient must have used the dopamine receptor-blocking drug for at least 3 months (or 1 month in patients aged >60 years).
Schooler-Kane criteria[38]
For research purposes, the Schooler-Kane criteria for TD require all four of the following to be met:
At least 3 months of cumulative antipsychotic exposure
Mild dyskinesias in 2 or more body areas or moderate dyskinesias in one body area
Presence of movements for at least 3 months, and
No other identifiable aetiologies of involuntary dyskinesias.
Abnormal Involuntary Movement Scale (AIMS)[40]
A 12-item, validated rating scale to evaluate TD, developed by the National Institute of Mental Health. It can be used to monitor the effects of long-term treatment with antipsychotics and the severity of TD over time. Items 1-7 assess involuntary movements across body regions. Score from 0 (no dyskinesia) to 4 (severe, maximal amplitude, and persistence during the observation of abnormal movements).
Items 8-12 assess global judgements, dental status, and nocturnal occurrence of movements. AIMS: toolbox of forms Opens in new window
Impact-TD[39]
A standardised clinician-rated instrument to assess the impact of TD on a patient's day-to-day life and functioning.[39] It includes 4 domains:
Social
Psychological/psychiatric
Physical
Vocational/educational/recreational.
Each domain is scored from 0 (no impact) to 3 (severe impact).[39]
Use of this content is subject to our disclaimer